HBM7020 - Otsuka
A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body (clinicaltrials.gov) - Oct 14, 2026 - P1 | N=63 | Recruiting | Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Not yet recruiting ➔ Recruiting 
Enrollment open • First-in-human • Immunology • Inflammatory Arthritis • Lupus • Rheumatoid Arthritis • Rheumatology • Scleroderma • Systemic Lupus Erythematosus • Systemic Sclerosis
http://clinicaltrials.gov/ct2/show/NCT07649265
 
Oct 14, 2026
 
Prev Next